Efficacy and Safety of Secukinumab in Japanese Patients...

  • Main
  • 2018 / 10
  • Efficacy and Safety of Secukinumab in Japanese Patients...

Efficacy and Safety of Secukinumab in Japanese Patients with Active Ankylosing Spondylitis: 24-week Results from an Open-label Phase 3 Study (MEASURE 2-J)

Kishimoto, Mitsumasa, Taniguchi, Atsuo, Fujishige, Ayako, Kaneko, Shuhei, Haemmerle, Sibylle, Porter, Brian O., Kobayashi, Shigeto
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Modern Rheumatology
DOI:
10.1080/14397595.2018.1538004
Date:
October, 2018
File:
PDF, 874 KB
english, 2018
Conversion to is in progress
Conversion to is failed